Smoking Relapse-Prevention Intervention for Cancer Patients
This trial is active, not recruiting.
|Treatments||usual care, smoking relapse prevention for cancer patients (srp-cap)|
|Sponsor||H. Lee Moffitt Cancer Center and Research Institute|
|Collaborator||National Cancer Institute (NCI)|
|Start date||January 2012|
|End date||March 2017|
|Trial size||441 participants|
|Trial identifier||NCT01630161, 5R01CA154596-02, MCC-16458|
The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Masking||single blind (outcomes assessor)|
Number of Participants with Relapse at 6 Months
time frame: 6 Months
Number of Participants with Relapse at 12 Months
time frame: 12 Months
Male or female participants at least 18 years old.
Inclusion Criteria: - Have smoked at least 10 cigarettes per day for at least one year prior to cancer diagnosis - Able to read and write English - Able to give informed consent - Have quit smoking after receiving their cancer diagnosis - Have not quit greater than 3 months prior Exclusion Criteria: - Individuals who have been abstinent for greater than 3 months are not included because they are less likely to relapse. A quit will be defined as self-reported no smoking for 24 hours. Individuals with metastatic disease will be excluded because participation in the study might be burdensome.
|Official title||Smoking Relapse-Prevention Intervention for Cancer Patients|
|Principal investigator||Vani Simmons, Ph.D.|
|Description||This study involves participation at four distinct time points over a one-year period. - Baseline assessment - 2-month follow-up telephone call - 6-month follow-up telephone call - 12-month follow-up telephone call|
Call for more information